Announcement and Circular Letter

Investor Relations

Listing documents Announcement and Circular Letter Performance Report

Announcement and Circular Letter

2025.07.22

VOLUNTARY ANNOUNCEMENT - KEY PRODUCT DB-1310 GRANTED U.S. FDA FAST TRACK DESIGNATION
2025.07.07

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025
2025.06.20

POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 20, 2025
2025.06.10

ANNOUNCEMENT MADE PURSUANT TO RULE 13.10 OF THE LISTING RULES
2025.06.05

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025
2025.05.28

FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON JUNE 20, 2025
2025.05.28

NOTICE OF ANNUAL GENERAL MEETING
2025.05.12

STABILIZING ACTIONS AND END OF STABILIZATION PERIOD

«
1
2
3
»

Scan the code to follow DualityBio official wechat

Phone：021-2601 8730

Address：Full floor, 11th floor, tower a, Datang International Plaza,China

Construction Engineering Group, No. 868 Yinghua Road, Pudong New Area, Shanghai